Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (ATYR)
NASDAQ:ATYR
Total Valuation
aTyr Pharma has a market cap or net worth of $76.19M. The enterprise value is -$7.95M.
Market Cap$76.19M
Enterprise Value-$7.95M
Share Statistics
aTyr Pharma has 97,986,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding97,986,630
Owned by Insiders2.43%
Owned by Institutions0.98%
Financial Efficiency
aTyr Pharma’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is -80.50%.
Return on Equity (ROE)-0.91
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-80.50%
Return on Capital Employed (ROCE)-0.83
Revenue Per Employee4.20K
Profits Per Employee-1.14M
Employee Count56
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of aTyr Pharma is ―. aTyr Pharma’s PEG ratio is 0.49.
PE Ratio―
PS Ratio1143.94
PB Ratio3.84
Price to Fair Value3.84
Price to FCF-3.89
Price to Operating Cash Flow-0.62
PEG Ratio0.49
Income Statement
In the last 12 months, aTyr Pharma had revenue of 235.00K and earned -64.02M in profits. Earnings per share was -0.86.
Revenue235.00K
Gross Profit235.00K
Operating Income-67.91M
Pretax Income-64.02M
Net Income-64.02M
EBITDA-66.37M
Earnings Per Share (EPS)-0.86
Cash Flow
In the last 12 months, operating cash flow was -62.92M and capital expenditures -71.00K, giving a free cash flow of -62.99M billion.
Operating Cash Flow-62.92M
Free Cash Flow-62.99M
Free Cash Flow per Share-0.64
Dividends & Yields
aTyr Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.90
52-Week Price Change-76.29%
50-Day Moving Average0.88
200-Day Moving Average3.47
Relative Strength Index (RSI)41.03
Average Volume (3m)4.83M
Important Dates
aTyr Pharma upcoming earnings date is Mar 12, 2026, After Close (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
aTyr Pharma as a current ratio of 5.48, with Debt / Equity ratio of 15.40%
Current Ratio5.48
Quick Ratio5.48
Debt to Market Cap<0.01
Net Debt to EBITDA-0.03
Interest Coverage Ratio0.00
Taxes
In the past 12 months, aTyr Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
aTyr Pharma EV to EBITDA ratio is -4.08, with an EV/FCF ratio of -3.92.
EV to Sales1.15K
EV to EBITDA-4.08
EV to Free Cash Flow-3.92
EV to Operating Cash Flow-3.92
Balance Sheet
aTyr Pharma has $90.20M in cash and marketable securities with $12.36M in debt, giving a net cash position of $77.84M billion.
Cash & Marketable Securities$90.20M
Total Debt$12.36M
Net Cash$77.84M
Net Cash Per Share$0.79
Tangible Book Value Per Share$0.94
Margins
Gross margin is -497.37%, with operating margin of -28899.57%, and net profit margin of -27243.83%.
Gross Margin-497.37%
Operating Margin-28899.57%
Pretax Margin-27243.40%
Net Profit Margin-27243.83%
EBITDA Margin-28244.26%
EBIT Margin-28899.57%
Analyst Forecast
The average price target for aTyr Pharma is $5.75, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$5.75
Price Target Upside637.18% Upside
Analyst ConsensusHold
Analyst Count8
Revenue Growth Forecast-19.15%
EPS Growth Forecast10.90%